Males seropositive for hepatitis B surface antigen are at risk of lower bone mineral density: the 2008᾿010 Korea National Health and Nutrition Examination Surveys

详细信息    查看全文

• 作者：Myong Ki Baeg ; Seung Kew Yoon ; Sun-Hye Ko ; Kyung-Do Han…
• 关键词：Hepatitis B virus ; Bone mineral density ; Hepatic osteodystrophy ; Viral hepatitis ; Osteoporosis
• 刊名：Hepatology International
• 出版年：2016
• 出版时间：May 2016
• 年：2016
• 卷：10
• 期：3
• 页码：470-477
• 全文大小：556 KB
• 参考文献：1.Leslie WD, Bernstein CN, Leboff MS. AGA technical review on osteoporosis in hepatic disorders. Gastroenterology 2003;125:941–966CrossRef PubMed
  2.Rouillard S, Lane NE. Hepatic osteodystrophy. Hepatology 2001;33:301–307CrossRef PubMed
  3.Guanabens N, Pares A. Liver and bone. Arch Biochem Biophys 2010;503:84–94CrossRef PubMed
  4.Nakchbandi IA, van der Merwe SW. Current understanding of osteoporosis associated with liver disease. Nat Rev Gastroenterol Hepatol 2009;6:660–670CrossRef PubMed
  5.Lopez-Larramona G, Lucendo AJ, Gonzalez-Castillo S, Tenias JM. Hepatic osteodystrophy: an important matter for consideration in chronic liver disease. World J Hepatol 2011;3:300–307CrossRef PubMed PubMedCentral
  6.Gonzalez-Calvin JL, Gallego-Rojo F, Fernandez-Perez R, Casado-Caballero F, Ruiz-Escolano E, Olivares EG. Osteoporosis, mineral metabolism, and serum soluble tumor necrosis factor receptor p55 in viral cirrhosis. J Clin Endocrinol Metab 2004;89:4325–4330CrossRef PubMed
  7.Gonzalez-Calvin JL, Mundi JL, Casado-Caballero FJ, Abadia AC, Martin-Ibanez JJ. Bone mineral density and serum levels of soluble tumor necrosis factors, estradiol, and osteoprotegerin in postmenopausal women with cirrhosis after viral hepatitis. J Clin Endocrinol Metab 2009;94:4844–4850CrossRef PubMed
  8.Corazza GR, Trevisani F, Di Stefano M, De Notariis S, Veneto G, Cecchetti L, et al. Early increase of bone resorption in patients with liver cirrhosis secondary to viral hepatitis. Dig Dis Sci 2000;45:1392–1399CrossRef PubMed
  9.Chen CC, Wang SS, Jeng FS, Lee SD. Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis? J Gastroenterol Hepatol 1996;11:417–421CrossRef PubMed
  10.Gallego-Rojo FJ, Gonzalez-Calvin JL, Munoz-Torres M, Mundi JL, Fernandez-Perez R, Rodrigo-Moreno D. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 1998;28:695–699CrossRef PubMed
  11.Bell H, Raknerud N, Falch JA, Haug E. Inappropriately low levels of gonadotrophins in amenorrhoeic women with alcoholic and non-alcoholic cirrhosis. Eur J Endocrinol 1995;132:444–449CrossRef PubMed
  12.Gonzalez-Calvin JL, Mundi JL, Casado FJ, Olivares EG. Bone mineral density and serum levels of estradiol and osteoprotegerin in postmenopausal women with viral cirrhosis. Gastroenterology 2004;126:1225–1226; author reply 1226
  13.Orsini LG, Pinheiro MM, Castro CH, Silva AE, Szejnfeld VL. Bone mineral density measurements, bone markers and serum vitamin D concentrations in men with chronic non-cirrhotic untreated hepatitis C. PLoS ONE 2013;8:e81652CrossRef PubMed PubMedCentral
  14.Duarte MP, Farias ML, Coelho HS, Mendonça LM, Stabnov LM, do Carmo d Oliveira M, Lamy RA, Oliveira DS. Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease. J Gastroenterol Hepatol 2001;16:1022–1027CrossRef PubMed
  15.Gaudio A, Pennisi P, Muratore F, Bertino G, Ardiri A, Pulvirenti I, et al. Reduction of volumetric bone mineral density in postmenopausal women with hepatitis C virus-correlated chronic liver disease: a peripheral quantitative computed tomography (pQCT) study. Eur J Intern Med 2012;23:656–660CrossRef PubMed
  16.Arase Y, Suzuki F, Suzuki Y, Akuta N, Kobayashi M, Sezaki H, et al. Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus. J Med Virol 2010;82:390–395CrossRef PubMed
  17.Dienstag JL. Hepatitis B virus infection. N Engl J Med 2008;359:1486–1500CrossRef PubMed
  18.Liang TJ. Hepatitis B: the virus and disease. Hepatology 2009;49:S13–S21CrossRef PubMed PubMedCentral
  19.Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 2006;43:S173–S181CrossRef PubMed
  20.Schiefke I, Fach A, Wiedmann M, Aretin AV, Schenker E, Borte G, et al. Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol 2005;11:1843–1847CrossRef PubMed PubMedCentral
  21.Wariaghli G, Mounach A, Achemlal L, Benbaghdadi I, Aouragh A, Bezza A, et al. Osteoporosis in chronic liver disease: a case-control study. Rheumatol Int 2010;30:893–899CrossRef PubMed
  22.Yenice N, Gumrah M, Mehtap O, Kozan A, Turkmen S. Assessment of bone metabolism and mineral density in chronic viral hepatitis. Turk J Gastroenterol 2006;17:260–266PubMed
  23.Lim H, Nguyen T, Choue R, Wang Y. Sociodemographic disparities in the composition of metabolic syndrome components among adults in South Korea. Diabetes Care 2012;35:2028–2035CrossRef PubMed PubMedCentral
  24.Yoon JY, Park HA, Kang JH, Kim KW, Hur YI, Park JJ, et al. Prevalence of dietary supplement use in Korean children and adolescents: insights from Korea National Health and Nutrition Examination Survey 2007-2009. J Korean Med Sci 2012;27:512–517CrossRef PubMed PubMedCentral
  25.Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640–1645CrossRef PubMed
  26.Lee J, Lee S, Jang S, Ryu OH. age-related changes in the prevalence of osteoporosis according to gender and skeletal site: the Korea national health and Nutrition Examination Survey 2008–2010. Endocrinol Metab (Seoul) 2013;28:180–191CrossRef
  27.Collier J. Bone disorders in chronic liver disease. Hepatology 2007;46:1271–1278CrossRef PubMed
  28.Raslan HM, Elhosary Y, Ezzat WM, Rasheed EA, Rasheed MA. The potential role of insulin-like growth factor 1, insulin-like growth factor binding protein 3 and bone mineral density in patients with chronic hepatitis C virus in Cairo, Egypt. Trans R Soc Trop Med Hyg 2010;104:429–432CrossRef PubMed
  29.Anastassakos C, Alexander GJ, Wolstencroft RA, Avery JA, Portmann BC, Panayi GS, et al. Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology 1988;94:999–1005PubMed
  30.Fang JW, Shen WW, Meager A, Lau JY. Activation of the tumor necrosis factor-alpha system in the liver in chronic hepatitis B virus infection. Am J Gastroenterol 1996;91:748–753PubMed
  31.Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 2003;111:1221–1230CrossRef PubMed PubMedCentral
  32.Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Spelsberg TC, Riggs BL. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology 1999;140:4367–4370PubMed
  33.Schafer JJ, Manlangit K, Squires KE. Bone health and human immunodeficiency virus infection. Pharmacotherapy 2013;33:665–682CrossRef PubMed
  
• 作者单位：Myong Ki Baeg (1)
  Seung Kew Yoon (1)
  Sun-Hye Ko (1)
  Kyung-Do Han (2)
  Hye Jin Choi (1)
  Si Hyun Bae (1)
  Jong Young Choi (1)
  Myung-Gyu Choi (1)
  
  1. Department of Internal Medicine, College of Medicine, The Catholic University of Korea, 222 Banpodaero, Seochogu, Seoul, 137-701, South Korea
  2. Department of Biostatistics, College of Medicine, The Catholic University of Korea, 222 Banpodaero, Seochogu, Seoul, 137-701, South Korea
  
• 刊物主题：Hepatology; Colorectal Surgery; Surgery;
• 出版者：Springer India
• ISSN：1936-0541

文摘

Background Hepatic osteodystrophy has been reported in patients with various chronic liver diseases, including liver cirrhosis. However, it has not been well investigated in patients with hepatitis B virus infection. The aim of this study was to investigate the association between hepatitis B surface antigen (HBsAg) seropositivity and bone mineral density (BMD) in a population representative of normal Koreans.